ArticleThe Malaysian journal of medical sciences : MJMS2025
Development and Evaluation of a Medication Adherence Measure for Inhaler Use Among Patients with Asthma.
Article in The Malaysian journal of medical sciences : MJMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Limited scales exist for assessing adherence among inhaler users, and information on validity and diagnostic characteristics is lacking. This study aimed to develop a Medication Adherence Measure for Inhaler Users (MAM-I) and assess its reliability, validity, and cutoff score for determining nonadherence in patients with asthma. Methods: A cross-sectional study, which included 145 patients with asthma, was conducted. The participants completed the Mini Asthma Quality of Life Questionnaire (MiniAQLQ), the Marlowe-Crowne Social Desirability Scale (MCSDS), and the 7-item MAM-I. The reliability of the scale was determined using Cronbach's alpha, and its validity was examined in terms of criterion, concurrent, predictive, and construct validity. The diagnostic characteristics and cutoff point for nonadherence to inhaler use were also evaluated using the receiver operating characteristic (ROC) curve, with asthma control at month 6 as the gold standard. Results: The MAM-I showed a Cronbach's alpha value of 0.784 at baseline and 0.749 at month 6. Significant correlations were found between the MAM-I scores and adherence scores ( Conclusion: The MAM-I shows satisfactory reliability and validity, with good diagnostic properties and a cutoff score of less than 15. This scale can be a helpful tool for identifying inhaler nonadherence in asthma management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.